CTNI-38. UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA

Buxton, M., Alexander, B., Berry, D., Cavenee, W., Colman, H., de Groot, J., Ellingson, B., Gordon, G., Khasraw, M., Lassman, A., Lee, E., Li, W., Lim, M., Mellinghoff, I., Mikkelsen, T., Nelli, A., Perry, J., Sulman, E., Tanner, K., … Cloughesy, T. (2022). CTNI-38. UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA. Neuro-Oncology, 24(Supplement_7), vii80–vii80. https://doi.org/10.1093/neuonc/noac209.303
Authors:
Meredith Buxton
Brian M. Alexander
Donald A. Berry
Webster K. Cavenee
Howard Colman
John de Groot
Benjamin M. Ellingson
Gary Gordon
Mustafa Khasraw
Andrew B. Lassman
Eudocia Q. Lee
Wenbin Li
Michael Lim
Ingo K. Mellinghoff
Tom Mikkelsen
Apoorva Nelli
James Perry
Erik P. Sulman
Kirk Tanner
Michael Weller
Patrick Y. Wen
W. K. Alfred Yung
Timothy F. Cloughesy
Affiliated Authors:
Andrew B. Lassman
Publication Type:
Article
Unique ID:
10.1093/neuonc/noac209.303
Journal:
Publication Date:
Data Source:
OpenAlex

Record Created: